A sponsored post popped up on my Instagram last week that captured my obsession with statement jewelry and my periodic check on developments in facial recognition technology: “Artist Designs Metal Jewelry to Block Facial Recognition Software from Tracking You”. Statement jewelry? Check. An indication of how stressed out people are by facial recognition technology? I think so. While an experimental project, it’s not a far stretch to imagine the design actually being sold and purchased.
News of Note for the Internet-Minded (8/30/19) – Minecraft AI, GPS Tracking Transparency and Sweat Checks
What becomes of old (popular) Twitch channels, is Walmart getting into the virtual currency game, could 5G mean safer self-driving vehicles, and more …
Rulemaking Effort Looks at “Emerging” and “Foundational” Technologies
Since January, Bureau of Industry (BIS) officials have been formulating an analytical framework for establishing controls on emerging technologies (which include biotechnology, artificial intelligence and machine learning technology, quantum information and sensing technology, additive manufacturing, and robotics). Recently on the Global Trade & Sanctions Law blog, colleagues Nancy A. Fischer, Stephan E. Becker, Matthew R. Rabinowitz and Sahar J. Hafeez provided an update on the process, while explaining why the timing of the rule will matter for companies for which export controls (and CFIUS) are a concern.
The “Commander-in-Tweet” Returns: When a Social Media Account Creates a Public Forum, Critics Get to Stay
Two years ago, we wrote about a possible First Amendment challenge involving Donald Trump’s practice of blocking certain Twitter users from his @realDonaldTrump account. While it was unclear at the time of our post whether the Knight First Amendment Institute at Columbia University—an organization that uses strategic litigation to preserve the freedoms of speech and the press—would pursue further action, the Knight Institute filed a complaint a few days later in the U.S. District Court for the Southern District of New York against Trump, then-White House Press Secretary Sean Spicer and Daniel Scavino, the White House Director of Social Media and Assistant to the President. On July 9, 2019, the U.S. Court of Appeals for the Second Circuit issued a decision regarding this First Amendment issue.
News of Note for the Internet-Minded (7/12/19) – Non-Fungible Tokens, VR Aptitude Tests and Alexa Hears You!
Prime phishing day is upon us; Google hangs on to social media aspirations by a Shoelace; the prospects of Apple’s AR glasses get cloudy; and more …
The Three Biggest (Non-IP) Legal Issues Faced by Blockchain-Based Platform Technology Providers
For all the excitement and promise of blockchain-based technology, it’s vital to remember that the very “newness” of a technology can lead to issues of basic legal compatibility. Few if any technologies magically create their own regulatory framework whole cloth, after all. For this reason, technology providers wishing to use the blockchain—or related distributed ledger technology (DLT)—in their own offerings necessarily must pay careful attention to how their particular blockchain-based technology will interact with the established (and evolving) contracts, laws and customer expectations encountered in the marketplace. Here are three of the biggest issues that await providers:
Be Careful that Bot Doesn’t Come Back to Bite You
Much like humans, bots come in all shapes and sizes. In social media networks, these bots can like what you post and even increase your followers. Companies use bots for all types of things—from booking a ride to giving makeup tutorials. Some bots can even solve your legal problems. Besides saving time and money, bots have the potential to reduce errors and increase a business’s customer base. But what happens when bots spy on users and share personal information? Or when they make racial slurs and offensive comments?
FDA Public Hearing on Regulation of CBD: Are Extract, Processing and Quality Control Technologies Potentially More Important than Ever in the Cannabis Industry?
On May 31, 2019 the FDA held a public hearing about cannabidiol (CBD) products. The day-long hearing saw comments and presentations from stakeholders ranging from nonprofit organizations like ASTM International to the Grocery Manufacturers Association, a food, beverage and consumer product trade association. Corporate entities in the cannabis industry also provided testimony, such as ingredient manufacturer Mile High Labs, which supplies products like CBD isolate and concentrate, and Socati, which provides high-CBD genetic varieties and extraction processes. Pharmaceutical companies like Zynerba Pharmaceuticals Inc., which produces the drug Connect-FX, were also present. Connect-FX is a CBD transdermal gel for treating Fragile X syndrome (Martin-Bell syndrome), a rare genetic disorder that causes developmental problems like intellectual disabilities. It is currently being evaluated as an experimental treatment for use in child patients in clinical trials.
Like the FTC Before It, the UK’s Competition and Markets Authority Puts Influencers on Alert
Cannabis, Yeast and the Quest for Cannabinoid Synthesis
CBD, CBG, CBA, CBN, THC—the race to find the holy grail of cannabinoid production is in full swing. Money flows abound, unicorn-hungry investors looking to capture market share are swirling around promising frontrunners with lucrative IP. One interesting segment of cannabis IP gaining traction focuses on cannabinoids synthesis from microorganisms such as yeast.